Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Moses

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Endocrinology|November 1, 1980
Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteinsM M Rechler, J Zapf, S P Nissley, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1982
Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopaM E Molitch, R H Goodman, K D Post, et al.
Obesity Research|June 9, 1998
Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy menC S Mantzoros, A D Liolios, N A Tritos, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronateH N Rosen, A C Moses, J Garber, et al.
The Journal of Clinical Investigation|December 1, 1990
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemiaA C Moses, H N Rosen, D E Moller, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1993
Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistanceJ S Flier, D E Moller, A C Moses, et al.
The Journal of Biological Chemistry|August 25, 1979
Characterization of a somatomedin (insulin-like growth factor) synthesized by fetal rat liver organ culturesM M Rechler, H J Eisen, O Z Higa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1993
Parenteral pamidronate prevents thyroid hormone-induced bone loss in ratsH N Rosen, E K Sullivan, V L Middlebrooks, et al.
Journal of Supramolecular Structure and Cellular Biochemistry|January 1, 1981
Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulinM M Rechler, S P Nissley, G L King, et al.
Diabetes, Obesity & Metabolism|February 7, 2015
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observationsG H Daniels, L Hegedüs, S P Marso, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Endocrinology|November 1, 1980
Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteinsM M Rechler, J Zapf, S P Nissley, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1982
Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopaM E Molitch, R H Goodman, K D Post, et al.
Obesity Research|June 9, 1998
Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy menC S Mantzoros, A D Liolios, N A Tritos, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronateH N Rosen, A C Moses, J Garber, et al.
The Journal of Clinical Investigation|December 1, 1990
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemiaA C Moses, H N Rosen, D E Moller, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1993
Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistanceJ S Flier, D E Moller, A C Moses, et al.
The Journal of Biological Chemistry|August 25, 1979
Characterization of a somatomedin (insulin-like growth factor) synthesized by fetal rat liver organ culturesM M Rechler, H J Eisen, O Z Higa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1993
Parenteral pamidronate prevents thyroid hormone-induced bone loss in ratsH N Rosen, E K Sullivan, V L Middlebrooks, et al.
Journal of Supramolecular Structure and Cellular Biochemistry|January 1, 1981
Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulinM M Rechler, S P Nissley, G L King, et al.
Diabetes, Obesity & Metabolism|February 7, 2015
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observationsG H Daniels, L Hegedüs, S P Marso, et al.
Pageof 9